ORTHOPEDIATRICS CORP (KIDS) Operating Income (Loss) USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Orthopediatrics Corp quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2024.
  • Orthopediatrics Corp Operating Income (Loss) for the quarter ending March 31, 2024 was -$9.72 M, a 13.2% decline year-over-year.
  • Orthopediatrics Corp Operating Income (Loss) for the twelve months ending March 31, 2024 was -$27.9 M, a 1.01% decline year-over-year.
  • Orthopediatrics Corp annual Operating Income (Loss) for 2023 was -$26.8 M, a 5.32% decline from 2022.
  • Orthopediatrics Corp annual Operating Income (Loss) for 2022 was -$25.4 M, a 40.9% decline from 2021.
  • Orthopediatrics Corp annual Operating Income (Loss) for 2021 was -$18 M, a 32.6% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$27.9 M -$9.72 M -$1.13 M -13.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$26.8 M -$8.07 M +$243 K +2.93% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 -$27 M -$4.51 M +$2.45 M +35.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$29.4 M -$5.59 M -$1.84 M -49.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-01
Q1 2023 -$27.6 M -$8.59 M -$2.21 M -34.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$25.4 M -$8.31 M -$2.75 M -49.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 -$22.7 M -$6.96 M -$3.32 M -91% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$19.3 M -$3.74 M -$897 K -31.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 -$18.4 M -$6.39 M -$413 K -6.91% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$18 M -$5.56 M +$7.18 M +56.4% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-03
Q3 2021 -$25.2 M -$3.64 M -$1.15 M -45.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 -$24.1 M -$2.85 M +$4.17 M +59.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$28.2 M -$5.97 M -$1.48 M -32.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$26.8 M -$12.7 M -$9.71 M -320% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-03
Q3 2020 -$17 M -$2.5 M -$959 K -62.3% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-03
Q2 2020 -$16.1 M -$7.02 M -$5.23 M -292% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-03
Q1 2020 -$10.9 M -$4.5 M -$1.78 M -65.5% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-03
Q4 2019 -$9.08 M -$3.03 M -$1.17 M -62.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$7.91 M -$1.54 M -$367 K -31.3% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 -$7.55 M -$1.79 M +$330 K +15.6% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 -$7.88 M -$2.72 M +$1.68 M +38.2% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 -$9.55 M -$1.87 M +$2.34 M +55.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 -$11.9 M -$1.17 M -$418 K -55.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-05
Q2 2018 -$11.5 M -$2.12 M -$1.44 M -213% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-05
Q1 2018 -$10 M -$4.4 M -$3.56 M -425% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-05
Q4 2017 -$6.47 M -$4.2 M -$952 K -29.3% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$5.52 M -$754 K -$230 K -43.9% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-07
Q2 2017 -$5.29 M -$677 K +$188 K +21.7% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-07
Q1 2017 -$5.48 M -$837 K +$649 K +43.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-07
Q4 2016 -$6.13 M -$3.25 M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$524 K Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 -$865 K Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$1.49 M Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.